Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0JTNND
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
h2H12-Compound 3
|
|||||
| Synonyms |
h2H12 compound 3
Click to Show/Hide
|
|||||
| Organization |
Seagen Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Acute myeloid leukemia [ICD11:2A60]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Antibody Name |
Anti-CD33 mAb humanized 2H12
|
Antibody Info | ||||
| Antigen Name |
Myeloid cell surface antigen CD33 (CD33)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
h2H12-compound 3 linker
|
|||||
| Conjugate Type |
Site-specific conjugation through reduced inter-chain cysteines.
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.